1. Fry CH, Kitney DG, Paniker J, Drake MJ, Kanai A, Andersson KE (2018) Fibrosis and the bladder: implications for function ICI-RS 2017. Neurourol Urodyn, 37(S4): S7-S12. [ DOI:10.1002/nau.23725] 2. Bentzen SM (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer, 6(9): 702-713. [ DOI:10.1038/nrc1950] 3. Zwaans BM, Chancellor MB, Lamb LE (2018) Modeling and treatment of radiation cystitis. Urol Clin North Am, 45(4): 649-659. 4. Jing C, Beesley C, Foster CS, Rudland PS, Fujii H, Ono T, et al. (2000) Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer. Cancer Res, 60(9): 2390-2398. 5. Zhang C, Liao Y, Liu P, Du Q, Liang Y, Ooi S, et al. (2020) FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics, 10(15): 6561-6580. [ DOI:10.7150/thno.44868] 6. Seo J, Yun J, Fukuda J, Chun YS (2021) Tumor-intrinsic FABP5 is a novel driver for colon cancer cell growth via the HIF-1 signaling pathway. Cancer Genet, 258: 151-156. [ DOI:10.1016/j.cancergen.2021.11.001] 7. Seo J, Jeong DW, Park JW, Lee KW, Fukuda J, Chun YS (2020) Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Commun Biol, 3(1): 638. [ DOI:10.1038/s42003-020-01367-5] 8. Wang J, Zhao S, Sun J, Wang X, Guan M, Yin J, et al. (2023) Oncogenic role and potential regulatory mechanism of fatty acid binding protein 5 based on a pan-cancer analysis. Sci Rep, 13(1): 4060. [ DOI:10.1038/s41598-023-30695-9] 9. Katoh M (2018) Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β-catenin signaling activation. Int J Mol Med, 42(2): 713-725. [ DOI:10.3892/ijmm.2018.3689] 10. Di X, Jin X, Xiang L, Gao X, Peng L, Wang W, et al. (2023) Survivin (BIRC5) regulates bladder fibrosis in a rat model of partial bladder outlet obstruction. Chin Med J (Engl), 136(1): 117-119. [ DOI:10.1097/CM9.0000000000002022] 11. Qi C, Zhang J, Chen X, Wan J, Wang J, Zhang P, et al. (2017) Hypoxia stimulates neural stem cell proliferation by increasing HIF-1α expression and activating Wnt/β-catenin signaling. Cell Mol Biol (Noisy-le-grand), 63(7): 12-19. [ DOI:10.14715/cmb/2017.63.7.2] 12. Hengrui L (2022) Toxic medicine used in Traditional Chinese Medicine for cancer treatment: are ion channels involved? J Tradit Chin Med, 42(6): 1019-1022. 13. Duan LJ, Qi J, Kong XJ, Huang T, Qian XQ, Xu D, et al. (2015) MiR-133 modulates TGF-β1-induced bladder smooth muscle cell hypertrophic and fibrotic response. Cell Signal, 27(2): 215-227. [ DOI:10.1016/j.cellsig.2014.11.001] 14. Liu Q, Wang R, Wang C, Li Y, Li A (2019) The protective role of Schwann cells in bladder smooth muscle cell fibrosis. Int J Clin Exp Pathol, 12(10): 3799-3806. 15. Yang F, Fang E, Mei H, Chen Y, Li H, Li D, et al. (2019) Cis-acting circ-CTNNB1 promotes β-catenin signaling and cancer progression via DDX3-mediated transactivation of YY1. Cancer Res, 79(3): 557-571. [ DOI:10.1158/0008-5472.CAN-18-1559] 16. Li Q, Hong Y, Chen J, Zhou X, Tian X, Yu Y, et al. (2022) Hypoxia-induced HIF1A expression promotes neurogenic bladder fibrosis via EMT and pyroptosis. Cells, 11(23): 3836. 17. Duh K, Funaro MG, DeGouveia W, Bahlani S, Pappas D, Najjar S, et al. (2018) Crosstalk between the immune system and neural pathways in interstitial cystitis/bladder pain syndrome. Discov Med, 25(139): 243-250. 18. Jaal J and Dörr W (2010) Radiation-induced late damage to the rat urinary bladder. Radiother Oncol, 94(2): 219-224. 19. Stewart FA, Oussoren Y, Luts A, Begg AC, Dewit L, Lebesque J, et al. (1994) Repair of normal tissue damage after radiotherapy: the role of dose fractionation and volume effects. Int J Radiat Biol, 66(5): S119-S126. 20. Dörr W and Bentzen SM (1999) Late functional effects of radiation on the urinary bladder. Radiother Oncol, 51(3): S5-S10. 21. Zwaans BM, Krueger S, Bartolone SN, Chancellor MB, Marples B, Lamb LE (2016) Modeling of chronic radiation-induced cystitis in mice. Adv Radiat Oncol, 1(4): 333-343. [ DOI:10.1016/j.adro.2016.07.004] 22. Pan J, Dai Q, Zhang T, Li C (2019) Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway. Cancer Cell Int, 19: 1-10. [ DOI:10.1186/s12935-019-0787-0] 23. Zhang L, He Z, Ma J, Wang J (2021) Radiation-induced cystitis: mechanisms and management strategies. Int J Radiat Res, 19(3): 411-420. 24. Chen Y, Li H, Wang W, Zhang T, Liu Y (2021) Wnt/β-catenin signaling pathway inhibitors: a promising therapeutic approach for fibrosis. Front Pharmacol, 12: 672527. 25. Zhou C, Zhang J, Wang Y, Liu J (2020) Role of circular RNAs in organ fibrosis. Front Genet, 11: 574156. 26. West CM and Barnett GC (2011) Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med, 3(8): 52. [ DOI:10.1186/gm268] 27. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys, 76(3): S10-S19. [ DOI:10.1016/j.ijrobp.2009.07.1754] 28. Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO (2010) Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys, 76(3): S123-S129. [ DOI:10.1016/j.ijrobp.2009.03.078] 29. Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU (2010) Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys, 76(3): S116-S122. [ DOI:10.1016/j.ijrobp.2009.02.090] 30. Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, et al. (2012) Late bladder toxicity after definitive radiotherapy for uterine cervical cancer. Anticancer Res, 32(2): 741-746. 31. Khan M, Ali A, Zubair M, et al. (2020) Dose-dependent bladder toxicity in pelvic radiotherapy: clinical correlations and mitigation strategies. Int J Radiat Res, 18(4): 569-578. 32. Singh R, Patel V, Kumar S (2022) Fibrotic remodeling of bladder tissue following radiation exposure: insights from experimental and clinical studies. Int J Radiat Res, 20(2): 125-133. 33. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, et al. (2009) Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer, 9(2): 134-142. [ DOI:10.1038/nrc2587]
|